REFINE news articles

 

 

From April 2026, the MRC Clinical Trials Unit at UCL will become the UCL Innovative Clinical Trials Unit. The MRC Clinical Trials Unit at UCL has always been defined by its dedication to impactful research, innovation, its culture of collaboration and mentorship, and its commitment to improving global health. The Innovative Clinical Trials Unit is committed to continuing to fu ...

Episode 73 of the Immunobuddies podcast with Dr. Ricky Frazer and Dr. Anna Olsson-Brown has been released, featuring REFINE clinical fellow Dr. Sophie Merrick discussing The REFINE trial, and how to get involved. Listen to Episode 73 here. ...

Episode 72 of the Immunobuddies podcast with Dr. Ricky Frazer and Dr. Anna Olsson-Brown has been released, featuring REFINE clinical fellow Dr. Sophie Merrick discussing dose, frequency and duration of immunotherapy. Listen to Episode 72 here.   ...

    Episode 71 of the Immunobuddies podcast with Dr. Ricky Frazer and Dr. Anna Olsson-Brown has been released, featuring REFINE clinical fellow Dr. Sophie Merrick discussing dose, frequency and duration of immunotherapy. Listen here.     ...

REFINE has been featured on the latest episode of the Trial Talk Podcast. This episode explores how the REFINE trial aims to improve the use of immunotherapy to treat cancer.    Sophie Merrick, a Clinical Fellow from the MRC CTU at UCL, talks about the challenges of using immunotherapy drugs and how REFINE is testing whether giving these drugs less frequently can still treat t ...